ストックスクリーナーアプリを入手
2.32
2.31%
-0.05
前日終値:
$2.37
開ける：
$2.38
24時間の取引高:
2.98M
Relative Volume:
0.34
時価総額：
$2.19B
収益：
$1.31M
当期純損益:
$-597.65M
株価収益率:
-2.3918
EPS:
-0.97
ネットキャッシュフロー:
$-425.62M
1週間 パフォーマンス:
-0.63%
1か月 パフォーマンス:
-3.93%
6か月 パフォーマンス:
-23.33%
1年 パフォーマンス:
-37.42%
1日の値動き範囲:
$2.30
$2.38
1週間の範囲:
$2.29
$2.47
52週間の値動き範囲:
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
IBRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.315 | 2.25B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.87 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.22 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.31 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.00 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.85 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | BTIG Research | Buy |
| 2023-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 開始されました | Jefferies | Buy |
Immunitybio Inc (IBRX) 最新ニュース
NK Cell Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
Detecting price anomalies in ImmunityBio Inc. with AIJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Is ImmunityBio Inc. stock entering bullish territory2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Using R and stats models for ImmunityBio Inc. forecastingJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Real time scanner hits for ImmunityBio Inc. explainedTrade Volume Summary & Accurate Trade Setup Notifications - Newser
Is ImmunityBio Inc. reversing from oversold territoryJuly 2025 Momentum & Reliable Intraday Trade Alerts - Newser
Measuring ImmunityBio Inc.’s beta against major indicesMarket Rally & Long-Term Growth Stock Strategies - Newser
Aug Sentiment: Can ImmunityBio Inc. stock double in the next yearWeekly Risk Summary & Advanced Technical Signal Analysis - khodrobank.com
Applying chart zones and confluence areas to ImmunityBio Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
ImmunityBio Inc. stock volume spike explainedDollar Strength & Safe Capital Growth Trade Ideas - Newser
Will ImmunityBio Inc. bounce back from current supportQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Custom strategy builders for tracking ImmunityBio Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
What’s next for ImmunityBio Inc. stock priceWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Should I hold or sell ImmunityBio Inc. nowJuly 2025 Action & High Accuracy Buy Signal Tips - khodrobank.com
How to build a custom watchlist for ImmunityBio Inc.Weekly Profit Report & Consistent Return Strategy Ideas - Newser
ImmunityBio Inc. stock prediction for this weekStop Loss & Low Drawdown Investment Strategies - Newser
Is ImmunityBio Inc. stock a smart retirement pickJuly 2025 Volume & Momentum Based Trading Ideas - khodrobank.com
What are the analyst revisions for DRUGIs ImmunityBio Inc. stock a good investment in YEARTrade Exit Summary & Real-Time Volume Analysis - khodrobank.com
Is ImmunityBio Inc. gaining market shareAnalyst Downgrade & Real-Time Market Trend Scan - khodrobank.com
Should value investors consider ImmunityBio Inc.July 2025 Sector Moves & Precise Trade Entry Recommendations - khodrobank.com
Can ImmunityBio Inc. stock double in the next year2025 Market Overview & AI Driven Price Predictions - khodrobank.com
Is ImmunityBio Inc. a speculative investmentJuly 2025 Final Week & Real-Time Stock Movement Alerts - khodrobank.com
Does ImmunityBio Inc. have high return on assetsTreasury Yields & Risk Managed Investment Strategies - خودرو بانک
Is ImmunityBio Inc.’s growth already priced inJuly 2025 Volume & Verified Stock Trade Ideas - khodrobank.com
ImmunityBio Inc. Charts Flash Early Recovery SignalsJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru
Does ImmunityBio Inc. have a sustainable dividendTrade Performance Summary & Step-by-Step Swing Trade Plans - khodrobank.com
What momentum shifts mean for ImmunityBio Inc.Weekly Trade Report & Fast Entry Momentum Trade Alerts - Newser
Is ImmunityBio Inc. stock technically oversoldAnalyst Downgrade & Low Risk Investment Opportunities - khodrobank.com
Fed Meeting: Is ImmunityBio Inc. forming a double bottomWeekly Trade Report & Safe Capital Investment Plans - khodrobank.com
Identifying reversal signals in ImmunityBio Inc.2025 Key Lessons & Technical Pattern Based Signals - Newser
What technical models suggest about ImmunityBio Inc.’s comeback2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
What’s ImmunityBio Inc.’s historical returnWeekly Volume Report & Trade Opportunity Analysis - khodrobank.com
Is ImmunityBio Inc. stock a value trapQuarterly Trade Summary & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Comparing ImmunityBio Inc. in custom built stock radarsEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser
ImmunityBio Inc. Chart Enters High Volatility Zone2025 Biggest Moves & High Return Stock Watch Alerts - beatles.ru
Neuroendocrine tumors Pipeline Analysis, 2025 by DelveInsight | RayzeBio, Inc., Camurus, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp - Barchart.com
Chart based analysis of ImmunityBio Inc. trendsJuly 2025 Summary & Community Verified Swing Trade Signals - Newser
Statistical indicators supporting ImmunityBio Inc.’s strengthQuarterly Risk Review & Low Risk High Reward Ideas - Newser
Signal strength of ImmunityBio Inc. stock in tech scannersQuarterly Profit Review & Daily Growth Stock Investment Tips - Newser
Advanced analytics toolkit walkthrough for ImmunityBio Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
ImmunityBio Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - thegnnews.com
Immunitybio Inc (IBRX) 財務データ
収益
当期純利益
現金流量
EPS
Immunitybio Inc (IBRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SOON-SHIONG PATRICK | See remarks |
Feb 22 '25 |
Option Exercise |
0.00 |
114,329 |
0 |
29,588,261 |
| Sachs David C. | Chief Financial Officer |
Feb 22 '25 |
Option Exercise |
0.00 |
40,650 |
0 |
241,480 |
| Adcock Richard | CEO & President |
Feb 22 '25 |
Option Exercise |
0.00 |
152,439 |
0 |
412,585 |
| Simon Barry J. | Director |
Feb 22 '25 |
Option Exercise |
0.00 |
15,243 |
0 |
3,249,024 |
| Simon Barry J. | Director |
Jan 22 '25 |
Option Exercise |
2.00 |
110,020 |
219,864 |
3,233,781 |
| Adcock Richard | CEO & President |
Dec 31 '24 |
Option Exercise |
0.00 |
34,483 |
0 |
277,621 |
| Sachs David C. | Chief Financial Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
30,397 |
0 |
216,235 |
| LAUER REGAN J | Chief Accounting Officer |
Dec 15 '24 |
Option Exercise |
0.00 |
21,031 |
0 |
115,365 |
1.13%
0.35%
大文字化:
|
ボリューム (24 時間):